FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894814928> ?p ?o ?g. }

• W2894814928 endingPage "1617" @default.
• W2894814928 startingPage "1605" @default.
• W2894814928 abstract "Background: Reduced MS disease activity with alemtuzumab versus subcutaneous interferon beta-1a (SC IFNB-1a) in core phase 2/3 studies was accompanied by increased incidence of infections that were mainly nonserious and responsive to treatment. Alemtuzumab efficacy was durable over 6 years. Objective: To evaluate infections over 6 years in alemtuzumab-treated patients. Methods: Three randomized trials (CAMMS223, Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) I, and CARE-MS II) compared two courses of alemtuzumab 12 mg with SC IFNB-1a 44 μg in patients with active relapsing-remitting MS. An extension study (CAMMS03409) provided further evaluation and as-needed alemtuzumab retreatment. Results: Infections occurred more frequently with alemtuzumab 12 mg than SC IFNB-1a during Years 1 (58.7% vs 41.3%) and 2 (52.6% vs 37.7%), but declined for alemtuzumab-treated patients in Years 3 (46.6%), 4 (42.8%), 5 (40.9%), and 6 (38.1%). Serious infections were uncommon (1.0%–1.9% per year). Infections were predominantly (>95%) mild to moderate and included upper respiratory tract infections, urinary tract infections, and mucocutaneous herpetic infections. Prophylactic acyclovir reduced herpetic infections. Lymphocyte counts after alemtuzumab therapy did not predict infection risk. Conclusion: Infections with alemtuzumab were mostly mild to moderate and decreased over time, consistent with preservation of components of protective immunity." @default.
• W2894814928 created "2018-10-12" @default.
• W2894814928 creator A5008022339 @default.
• W2894814928 creator A5008598861 @default.
• W2894814928 creator A5009824403 @default.
• W2894814928 creator A5020016996 @default.
• W2894814928 creator A5021591786 @default.
• W2894814928 creator A5051534137 @default.
• W2894814928 creator A5053403281 @default.
• W2894814928 creator A5055135931 @default.
• W2894814928 creator A5063615479 @default.
• W2894814928 creator A5065646936 @default.
• W2894814928 creator A5069092257 @default.
• W2894814928 creator A5069727178 @default.
• W2894814928 creator A5078067575 @default.
• W2894814928 date "2018-10-05" @default.
• W2894814928 modified "2023-10-06" @default.
• W2894814928 title "Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study" @default.
• W2894814928 cites W1584948886 @default.
• W2894814928 cites W1666336517 @default.
• W2894814928 cites W1988510033 @default.
• W2894814928 cites W2006632144 @default.
• W2894814928 cites W2015285729 @default.
• W2894814928 cites W2021724645 @default.
• W2894814928 cites W2044022462 @default.
• W2894814928 cites W2076870975 @default.
• W2894814928 cites W2087764276 @default.
• W2894814928 cites W2106948231 @default.
• W2894814928 cites W2107422246 @default.
• W2894814928 cites W2112044962 @default.
• W2894814928 cites W2124598981 @default.
• W2894814928 cites W2125241365 @default.
• W2894814928 cites W2148306011 @default.
• W2894814928 cites W2148766438 @default.
• W2894814928 cites W2154775026 @default.
• W2894814928 cites W2158202057 @default.
• W2894814928 cites W2265012467 @default.
• W2894814928 cites W2531523188 @default.
• W2894814928 cites W2626225244 @default.
• W2894814928 cites W2744884072 @default.
• W2894814928 cites W2746924405 @default.
• W2894814928 doi "https://doi.org/10.1177/1352458518796675" @default.
• W2894814928 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6764150" @default.
• W2894814928 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30289355" @default.
• W2894814928 hasPublicationYear "2018" @default.
• W2894814928 type Work @default.
• W2894814928 sameAs 2894814928 @default.
• W2894814928 citedByCount "52" @default.
• W2894814928 countsByYear W28948149282019 @default.
• W2894814928 countsByYear W28948149282020 @default.
• W2894814928 countsByYear W28948149282021 @default.
• W2894814928 countsByYear W28948149282022 @default.
• W2894814928 countsByYear W28948149282023 @default.
• W2894814928 crossrefType "journal-article" @default.
• W2894814928 hasAuthorship W2894814928A5008022339 @default.
• W2894814928 hasAuthorship W2894814928A5008598861 @default.
• W2894814928 hasAuthorship W2894814928A5009824403 @default.
• W2894814928 hasAuthorship W2894814928A5020016996 @default.
• W2894814928 hasAuthorship W2894814928A5021591786 @default.
• W2894814928 hasAuthorship W2894814928A5051534137 @default.
• W2894814928 hasAuthorship W2894814928A5053403281 @default.
• W2894814928 hasAuthorship W2894814928A5055135931 @default.
• W2894814928 hasAuthorship W2894814928A5063615479 @default.
• W2894814928 hasAuthorship W2894814928A5065646936 @default.
• W2894814928 hasAuthorship W2894814928A5069092257 @default.
• W2894814928 hasAuthorship W2894814928A5069727178 @default.
• W2894814928 hasAuthorship W2894814928A5078067575 @default.
• W2894814928 hasBestOaLocation W28948149281 @default.
• W2894814928 hasConcept C126322002 @default.
• W2894814928 hasConcept C203014093 @default.
• W2894814928 hasConcept C2779015954 @default.
• W2894814928 hasConcept C2780640218 @default.
• W2894814928 hasConcept C2780805593 @default.
• W2894814928 hasConcept C2908698914 @default.
• W2894814928 hasConcept C2911091166 @default.
• W2894814928 hasConcept C2994247566 @default.
• W2894814928 hasConcept C71924100 @default.
• W2894814928 hasConcept C90924648 @default.
• W2894814928 hasConceptScore W2894814928C126322002 @default.
• W2894814928 hasConceptScore W2894814928C203014093 @default.
• W2894814928 hasConceptScore W2894814928C2779015954 @default.
• W2894814928 hasConceptScore W2894814928C2780640218 @default.
• W2894814928 hasConceptScore W2894814928C2780805593 @default.
• W2894814928 hasConceptScore W2894814928C2908698914 @default.
• W2894814928 hasConceptScore W2894814928C2911091166 @default.
• W2894814928 hasConceptScore W2894814928C2994247566 @default.
• W2894814928 hasConceptScore W2894814928C71924100 @default.
• W2894814928 hasConceptScore W2894814928C90924648 @default.
• W2894814928 hasIssue "12" @default.
• W2894814928 hasLocation W28948149281 @default.
• W2894814928 hasLocation W28948149282 @default.
• W2894814928 hasLocation W28948149283 @default.
• W2894814928 hasLocation W28948149284 @default.
• W2894814928 hasOpenAccess W2894814928 @default.
• W2894814928 hasPrimaryLocation W28948149281 @default.
• W2894814928 hasRelatedWork W1666336517 @default.
• W2894814928 hasRelatedWork W1983662281 @default.
• W2894814928 hasRelatedWork W2145526572 @default.

• next